Daiwa-Securities-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,307
Total Value
15007955
Accession Number
0001481045-25-000006
Form Type
13F-HR
Manager Name
Daiwa-Securities-Group
Data Enrichment
93% identified
1,218 identified89 unidentified

Holdings

1,307 positions • $15.0M total value
Manager:
Search and click to pin securities to the top
Page 58 of 64
Pacira BioSciences, Inc.
Shares:169
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Immunocore Holdings plc
Shares:138
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
NOVAVAX INC
Shares:652
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
INDIVIOR PLC
Shares:450
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Centessa Pharmaceuticals plc
Shares:294
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Innoviva, Inc.
Shares:238
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Vera Therapeutics, Inc.
Shares:182
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
COLLEGIUM PHARMACEUTICAL, INC
Shares:127
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Aurinia Pharmaceuticals Inc.
Shares:528
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Adaptive Biotechnologies Corp
Shares:530
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Structure Therapeutics Inc.
Shares:226
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Wave Life Sciences Ltd.
Shares:503
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
OCULAR THERAPEUTIX, INC
Shares:593
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Dyne Therapeutics, Inc.
Shares:371
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Syndax Pharmaceuticals Inc
Shares:314
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
GERON CORP
Shares:2.2K
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$15.0M)
Evolus, Inc.
Shares:262
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
81369Y605
Shares:67
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
Enliven Therapeutics, Inc.
Shares:152
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
GENMAB A/S
Shares:159
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)